Announced
Completed
AIMMUNE THERAPEUTICS INC / NESTLE / Acquisition / Public
Synopsis
Equity investment in Aimmune Therapeutics, a biopharmaceutical company developing CODIT™ (Characterized Oral Desensitization ImmunoTherapy), by Nestlé Health Science.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.